CING
NASDAQ · Pharmaceuticals
Cingulate Inc
$5.27
+0.04 (+0.76%)
Open$5.26
Previous Close$5.23
Day High$5.30
Day Low$5.02
52W High$11.89
52W Low$3.20
Volume—
Avg Volume459.0K
Market Cap64.07M
P/E Ratio—
EPS$-4.42
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+172.9% upside
Current
$5.27
$5.27
Target
$14.38
$14.38
$9.95
$14.38 avg
$17.66
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 8.37M | 8.17M | 9.32M |
| Net Income | 2.92M | 2.10M | 3.15M |
| Profit Margin | 34.9% | 25.8% | 33.8% |
| EBITDA | 4.25M | 3.98M | 4.18M |
| Free Cash Flow | 2.06M | 2.44M | 3.61M |
| Rev Growth | +14.6% | -6.6% | +11.6% |
| Debt/Equity | 0.37 | 0.32 | 0.41 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |